Which hedge funds own DNA? GINKGO BIOWORKS HOLDINGS INC, Q2 2026 13F holders
23 of the hedge funds tracked by WhaleCreep disclosed a position in DNA (GINKGO BIOWORKS HOLDINGS INC) in their Q2 2026 13F filings, worth $84.1m in total. The largest holder by portfolio weight is Anchorage Capital Group, L.L.C. at 3.8% of its book. 6 managers opened a new position this quarter: Balance Capital Partners L.P., Trexquant Investment LP, Walleye Capital LLC, Citadel Advisors LLC. 3 exited: Atom Investors LP, Engineers Gate Manager LP, Quantbot Technologies LP.
23tracked managers holding
6opened this quarter
3exited this quarter
Which hedge funds hold DNA? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Anchorage Capital Group, L.L.C. | Q2 2026 | 3.8% | $17.3m | 1,746,363 | 0% | held |
| Balance Capital Partners L.P. | Q2 2026 | 1.4% | $2.0m | 199,009 | – | new |
| Prescott Group Capital Management, L.L.C. | Q2 2026 | 0.5% | $5.4m | 541,845 | 0% | held |
| Viking Global Investors LP | Q2 2026 | 0.1% | $35.4m | 3,577,128 | 0% | held |
| Numerai GP LLC | Q2 2026 | 0.1% | $1.0m | 104,602 | -40% | reduced |
| Fny Investment Advisers, LLC | Q2 2026 | 0.1% | $148.0k | 14,966 | -3% | reduced |
| Caxton Associates LLP | Q2 2026 | 0.0% | $1.5m | 154,647 | 125% | added |
| Casdin Capital, LLC | Q2 2026 | 0.0% | $361.6k | 36,493 | 0% | held |
| Tudor Investment Corp ET AL | Q2 2026 | 0.0% | $3.3m | 335,710 | -28% | reduced |
| Entropy Technologies, LP | Q2 2026 | 0.0% | $138.4k | 13,968 | 29% | added |
| Millennium Management LLC | Q2 2026 | 0.0% | $6.3m | 638,676 | 31% | added |
| Graham Capital Management, L.P. | Q2 2026 | 0.0% | $115.2k | 11,620 | -68% | reduced |
| Aqr Capital Management LLC | Q2 2026 | 0.0% | $6.2m | 621,625 | 111% | added |
| Aquatic Capital Management LLC | Q2 2026 | 0.0% | $47.8k | 4,828 | 164% | added |
| ExodusPoint Capital Management, LP | Q2 2026 | 0.0% | $148.3k | 14,969 | -77% | reduced |
| Trexquant Investment LP | Q2 2026 | 0.0% | $178.4k | 18,004 | – | new |
| D. E. Shaw & Co., Inc. | Q2 2026 | 0.0% | $1.5m | 151,356 | 457% | added |
| Walleye Capital LLC | Q2 2026 | 0.0% | $188.9k | 19,066 | – | new |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $1.3m | 130,935 | – | new |
| Marshall Wace, LLP | Q2 2026 | 0.0% | $772.4k | 77,937 | – | new |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $599.1k | 60,454 | -5% | reduced |
| Squarepoint Ops LLC | Q2 2026 | 0.0% | $155.5k | 15,689 | -71% | reduced |
| Quarry LP | Q2 2026 | 0.0% | $832 | 84 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Atom Investors LP | 0.0% | $110.2k |
| Engineers Gate Manager LP | 0.0% | $273.2k |
| Quantbot Technologies LP | 0.0% | $12.3k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| baillie_gifford | Q2 2026 | 0.0% |
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of DNA changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 25 | $113.2m |
| Q1 2026 | 22 | $62.7m |
| Q4 2025 | 6 | $53.4m |
| Q3 2025 | 4 | $102.0m |
| Q2 2025 | 4 | $79.2m |
| Q1 2025 | 6 | $41.6m |
| Q4 2024 | 6 | $72.4m |
| Q3 2024 | 6 | $61.7m |
Counts every tracked manager that disclosed DNA in that quarter's filing, including managers that have since stopped filing.